Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2026 11:58 ET | Source: Research and Markets

Radioligand Therapy Market Expected to Surge to $10.72 Billion by 2030: Upsurge in Cancer Cases Fuelling Industry Growth at 10% CAGR

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Radioligand Therapy Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights, including...
April 02, 2026 11:34 ET | Source: Research and Markets

Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Throat Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The throat cancer market has exhibited significant growth...
March 31, 2026 11:04 ET | Source: Research and Markets

Precision Medicine Software Market Outlook 2026-2030 & 2035 - Philips, Palantir Technologies, and Tempus Labs Lead the $2.82 Billion Industry

Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine Software Market Report 2026" has been added to ResearchAndMarkets.com's offering. The precision medicine software market is...
March 31, 2026 11:00 ET | Source: S4H – Stage4Hope

Stage4Hope™ Commits $2.5 Million to Memorial Sloan Kettering Cancer Center to Accelerate Breakthrough Cancer Research

Stage4Hope has announced a $2.5 million multi-year research commitment to Memorial Sloan Kettering Cancer Center (MSK) to support cancer research.
March 30, 2026 06:00 ET | Source: Research and Markets

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Bile Duct Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bile duct cancer market is witnessing robust...
March 30, 2026 05:42 ET | Source: Research and Markets

Paranasal Sinus Cancer Markets and Competition Outlook 2026-2030 - Precision Oncology, Minimally Invasive Surgeries, and Expanded Cancer Care Models Drive Revenue Growth

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Paranasal Sinus Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The paranasal sinus cancer market has shown...
March 30, 2026 05:08 ET | Source: Research and Markets

Artificial Intelligence in Oncology: Assessment of Market Opportunities by Region and Market, 2026-2030 - North America Leads but Asia-Pacific is Emerging Fast

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Oncology Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers a comprehensive...
March 27, 2026 11:15 ET | Source: Research and Markets

Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Bispecific T-Cell Engagers Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bispecific T-cell engagers market is...
March 24, 2026 09:46 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...
March 24, 2026 08:37 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...